Advances in bronchiectasis.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 17 5 2019
pubmed: 17 5 2019
medline: 16 5 2020
Statut: ppublish

Résumé

Bronchiectasis is a chronic inflammatory condition with a diverse aetiology including recurrent infections, genetic abnormalities, immunodeficiency and autoimmune disorders. The prevalence has increased over the past few years and this may be due to better imaging and diagnostic techniques. Management remains the emphasis for improving symptoms and reducing exacerbations. This article focuses on highlighting the latest data released since 2014 on new diagnostic techniques as well as potential future pharmacological and non-pharmacological treatment options for patients with bronchiectasis.

Identifiants

pubmed: 31092516
pii: 19/3/230
doi: 10.7861/clinmedicine.19-3-230
pmc: PMC6542217
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-233

Informations de copyright

© Royal College of Physicians 2019. All rights reserved.

Références

Lancet Respir Med. 2014 Jun;2(6):455-63
pubmed: 24717640
Chest. 2018 Apr;153(4):986-993
pubmed: 29355548
Thorax. 2019 Jan;74(Suppl 1):1-69
pubmed: 30545985
Chron Respir Dis. 2019 Jan-Dec;16:1479972318790269
pubmed: 30101613
PLoS One. 2017 Feb 7;12(2):e0170622
pubmed: 28170403
Eur Respir J. 2018 Jan 25;51(1):
pubmed: 29371383
Lancet Respir Med. 2014 Sep;2(9):738-49
pubmed: 25154045
Chest. 2017 May;151(5):953-954
pubmed: 28483128
Cochrane Database Syst Rev. 2014 Jun 10;(6):CD010327
pubmed: 24913725
Lancet Respir Med. 2019 Mar;7(3):213-226
pubmed: 30658914
Eur Respir J. 2018 Jan 25;51(1):
pubmed: 29371384
Respir Res. 2014 Apr 15;15:44
pubmed: 24731015
Chest. 2017 Aug;152(2):368-378
pubmed: 28554732

Auteurs

Karuna Sapru (K)

Royal Infirmary of Edinburgh, Edinburgh, UK k.sapru@nhs.net.

Adam T Hill (AT)

NHS Education for Scotland, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH